Hikma Pharmaceuticals PLC (HIK) - Total Assets

Latest as of June 2025: GBX5.55 Billion GBX ≈ $675.76K USD

Based on the latest financial reports, Hikma Pharmaceuticals PLC (HIK) holds total assets worth GBX5.55 Billion GBX (≈ $675.76K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check HIK cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Hikma Pharmaceuticals PLC - Total Assets Trend (2002–2024)

This chart illustrates how Hikma Pharmaceuticals PLC's total assets have evolved over time, based on quarterly financial data. Explore Hikma Pharmaceuticals PLC (HIK) investment intensity to see how much of total assets are deployed in long-term investments.

Hikma Pharmaceuticals PLC - Asset Composition Analysis

Current Asset Composition (December 2024)

Hikma Pharmaceuticals PLC's total assets of GBX5.55 Billion consist of 44.1% current assets and 55.9% non-current assets.

Asset Category	Amount (GBX)	% of Total Assets
Cash & Equivalents	GBX0.00	3.7%
Accounts Receivable	GBX905.00 Million	17.6%
Inventory	GBX986.00 Million	19.2%
Property, Plant & Equipment	GBX0.00	0.0%
Intangible Assets	GBX774.00 Million	15.1%
Goodwill	GBX382.00 Million	7.4%

Asset Composition Trend (2002–2024)

This chart illustrates how Hikma Pharmaceuticals PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Hikma Pharmaceuticals PLC market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Hikma Pharmaceuticals PLC's current assets represent 44.1% of total assets in 2024, a decrease from 67.9% in 2002.
Cash Position: Cash and equivalents constituted 3.7% of total assets in 2024, down from 12.8% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 0.0% in 2002.
Asset Diversification: The largest asset category is inventory at 19.2% of total assets.

Hikma Pharmaceuticals PLC Competitors by Total Assets

Key competitors of Hikma Pharmaceuticals PLC based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Aurobindo Pharma Limited NSE:AUROPHARMA	India	Rs585.02 Billion
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥14.18 Billion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	China	CN¥10.37 Billion
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	China	CN¥7.28 Billion
Xeris Pharmaceuticals Inc NASDAQ:XERS	USA	$392.01 Million
Procter & Gamble Health Limited NSE:PGHL	India	Rs8.94 Billion

Hikma Pharmaceuticals PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.24	1.66	1.76
Quick Ratio	0.72	0.98	1.12
Cash Ratio	0.00	0.00	0.00
Working Capital	GBX501.00 Million	GBX905.00 Million	GBX808.00 Million

Hikma Pharmaceuticals PLC - Advanced Valuation Insights

This section examines the relationship between Hikma Pharmaceuticals PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.82
Latest Market Cap to Assets Ratio	0.01
Asset Growth Rate (YoY)	9.7%
Total Assets	GBX5.13 Billion
Market Capitalization	$39.53 Million USD

Valuation Analysis

Below Book Valuation: The market values Hikma Pharmaceuticals PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Hikma Pharmaceuticals PLC's assets grew by 9.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Hikma Pharmaceuticals PLC (2002–2024)

The table below shows the annual total assets of Hikma Pharmaceuticals PLC from 2002 to 2024.

Year	Total Assets	Change
2024-12-31	GBX5.13 Billion ≈ $624.54K	+9.68%
2023-12-31	GBX4.68 Billion ≈ $569.42K	+4.67%
2022-12-31	GBX4.47 Billion ≈ $543.99K	+2.26%
2021-12-31	GBX4.37 Billion ≈ $531.95K	+5.73%
2020-12-31	GBX4.13 Billion ≈ $503.11K	+5.22%
2019-12-31	GBX3.93 Billion ≈ $478.17K	+12.38%
2018-12-31	GBX3.50 Billion ≈ $425.48K	+3.22%
2017-12-31	GBX3.39 Billion ≈ $412.22K	-22.35%
2016-12-31	GBX4.36 Billion ≈ $530.85K	+68.00%
2015-12-31	GBX2.60 Billion ≈ $315.98K	+15.37%
2014-12-31	GBX2.25 Billion ≈ $273.88K	+16.69%
2013-12-31	GBX1.93 Billion ≈ $234.70K	+11.50%
2012-12-31	GBX1.73 Billion ≈ $210.50K	+9.80%
2011-12-31	GBX1.58 Billion ≈ $191.71K	+41.21%
2010-12-31	GBX1.12 Billion ≈ $135.76K	+9.10%
2009-12-31	GBX1.02 Billion ≈ $124.44K	+5.82%
2008-12-31	GBX966.46 Million ≈ $117.59K	+8.10%
2007-12-31	GBX894.04 Million ≈ $108.78K	+83.07%
2006-12-31	GBX488.36 Million ≈ $59.42K	+22.71%
2005-12-31	GBX397.96 Million ≈ $48.42K	+61.46%
2004-12-31	GBX246.48 Million ≈ $29.99K	+109.13%
2003-12-31	GBX117.86 Million ≈ $14.34K	+24.25%
2002-12-31	GBX94.86 Million ≈ $11.54K	--

About Hikma Pharmaceuticals PLC

LSE:HIK UK Drug Manufacturers - Specialty & Generic

Market Cap

$39.53 Million

GBX324.87 Billion GBX

Market Cap Rank

#22821 Global

#184 in UK

Share Price

GBX1467.00

Change (1 day)

+0.00%

52-Week Range

GBX1191.00 - GBX2070.00

All Time High

GBX2408.28